For marketplaces, clinics, and partners
Your guide, in the space between
Guided voice support that holds therapeutic continuity between sessions.
Guided voice support that holds therapeutic continuity between sessions.
ReMind reinforces the work you do in session. No advice, no behavioural suggestions, just continuity.
The focus is what you and your guide settle on together, the work you're doing now. ReMind holds it through the week, so it doesn't fade between visits.
Speak in the morning. Receive a guided reflection later in the day. The space between sessions is part of the work, rather than a gap to wait through.
ReMind completed a three-week feasibility and acceptability study with 27 participants on Prolific, screened for moderate self-reported anxiety in a workplace context, using validated instruments (uMARS and the System Usability Scale). The study was designed to assess whether the experience is usable, acceptable, and meaningful, and to preserve our regulatory posture for future MHRA classification.
Rated Excellent. Top band for usability across digital health products.
The System Usability Scale (SUS) is a 10-item questionnaire used to measure perceived usability. Scores range from 0 to 100. A score above 68 is considered above average, and above 80.3 is rated Excellent. It is one of the most widely used usability measures in software research.
Source ↗Above published benchmarks for mental health apps.
The user Mobile App Rating Scale (uMARS) is a validated tool for rating the quality of health apps. Participants rate the app across six dimensions: engagement, functionality, aesthetics, information quality, subjective quality, and perceived impact. Scores range from 1 (inadequate) to 5 (excellent). Published benchmarks for well-regarded mental health apps typically fall between 3.5 and 4.0.
Source ↗70% of participants scored 7 or above on intent to use ReMind between clinical sessions.
"The reflections it provided felt personalised but unbiased, like an outsider not judging you but providing insight into your patterns." Participant · feasibility study
"I treated it like a companion. It gave me the confidence to move forward in some situations. In others, it helped me to regulate my feelings so that I felt able to cope." Participant · feasibility study
"It was a great tool for reinforcing my actual sessions and putting my mind at ease particularly with the feedback I was getting back." Participant · feasibility study
The pilot deployed ReMind's full supervised architecture: a clinician-authored guidance profile and a named guide receiving the voice check-ins. The next phase, in partnership with marketplaces and clinics, replaces the researcher-guide with the patient's own clinician, scaling the supervised model and generating the evidence base for medical device classification at Series A. While the pilot focused on workplace anxiety, the underlying architecture supports varied indications through different guidance profiles, with each new clinical context shaped by the relevant clinician authoring or adapting a profile.
ReMind is designed so that patient data lives with patients, not with us. Voice content is uniquely sensitive and is treated accordingly throughout the system.
Recordings, transcripts, and reflections are stored on the patient's device and synced to their personal iCloud. ReMind does not hold user content in central storage. Patients can export everything at any time, and can delete their account at any time. Their data leaves with them, because it was already theirs.
Each voice check-in is a discrete sharing decision. Patients choose, in the moment, whether to share that day's recording with their guide. Nothing is shared by default.
Recordings shared with a guide are encrypted on the patient's device, transmitted as ciphertext, and decrypted only on the guide's device for playback. ReMind cannot read the content of what's shared.
Once shared, recordings are available to the guide within a 72-hour review window, then automatically removed from the system. If a patient deletes their account, any shared recordings are removed alongside it.
ReMind extends the therapeutic relationships your organisation already supports. Your clinicians remain at the centre, assigning patients a guidance profile and receiving shared check-ins within the data posture above. Implementation is light; the work that matters is in the clinical content your organisation already has.
Most clinicians start with profiles drawn from a shared library, calibrated by experienced clinical authors for common presentations. Assignment to a patient takes minutes. Clinicians who want fuller control can author or adapt profiles to fit their specific practice, but this is optional rather than required. The ongoing time commitment is bounded: listening to the recordings patients choose to share, when it's useful to do so.
Patients arrive at sessions with the focus of the work already held through the week. Shared recordings give clinicians a window into patient experience between sessions, when patients choose to share them. The continuity reduces time spent re-establishing context at the start of each session and supports more grounded clinical conversation. The pilot data suggests strong patient engagement; the broader clinical outcome case will be built through partner deployments.
The tools to manage guidance profiles, invite patients into their care, and listen to recordings patients choose to share. The clinician-side surface is deliberately focused on the work that matters most: shaping ReMind through the profile, and hearing what the patient chose to share
A short voice check-in that fits into the morning. A guided audio reflection later in the day, shaped by the profile their clinician has assigned. The choice, each day, of whether to share that recording with their clinician. A sense of continuity with the work they're doing in session, carried through the week.
We work with select early partners on structured one-year deployments. ReMind is provided at no cost during the year, in exchange for usability and outcomes data that helps refine the product and supports the regulatory pathway. The goal is for ReMind to become a benefit you offer your patients, with commercial terms shaped by what we learn together.
Early partnerships shape the clinical evidence base and the commercial shape of the year ahead.
ReMind is voice support for therapeutic continuity, built on a platform that lets clinicians encode their craft into structured guidance profiles. We're positioning as the clinician-supervised alternative to autonomous AI therapy chatbots, in a market where regulators, clinicians, and patients are all becoming more cautious about unsupervised AI in mental health.
Our pilot completed in May 2026 with strong usability and acceptability results. We're now raising a seed round to fund a year of real-world deployment through marketplace and clinic partnerships, a follow-on clinical study, and regulatory groundwork toward Class IIa medical device classification at Series A. Commercial structure follows a B2B2C model: free deployment during the partnership year in exchange for evidence, transitioning to per-patient or per-seat licensing with partner organisations once deployment is proven. The same platform underpins a second product surface in development: ReMind as research instrumentation for longitudinal experience capture in clinical trials, an emergent finding from the pilot.
Tell us where you are and what you're exploring. We'll come back within a few working days.
